Statements in which the resource exists as a subject.
PredicateObject
rdf:type
skos:definition
"An indazole substituted at position 3 by a 2-(pyridin-2-yl)vinyl group and at position 6 by a 2-(N-methylaminocarboxy)phenylsulfanyl group. Used for the treatment of advanced renal cell carcinoma after failure of a first line systemic treatment." []
skos:inScheme
skos:prefLabel
axitinib
skos:altLabel
N-methyl-2-({3-[(E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl}sulfanyl)benzamide
skos:notation
ChemIDplus:319460-85-0 "CAS Registry Number", CiteXplore:20740300 "PubMed citation", CiteXplore:21301929 "PubMed citation", CiteXplore:21670972 "PubMed citation", CiteXplore:22168366 "PubMed citation", CiteXplore:22170007 "PubMed citation", CiteXplore:22248343 "PubMed citation", CiteXplore:22504156 "PubMed citation", CiteXplore:22545314 "PubMed citation", CiteXplore:22549112 "PubMed citation", CiteXplore:22644797 "PubMed citation", CiteXplore:22683928 "PubMed citation", CiteXplore:22699078 "PubMed citation", CiteXplore:22706540 "PubMed citation", CiteXplore:22733795 "PubMed citation", CiteXplore:22787405 "PubMed citation", KEGG DRUG:319460-85-0 "CAS Registry Number", KEGG DRUG:D03218 "KEGG DRUG", Reaxys:11333336 "Reaxys Registry Number", Wikipedia:Axitinib "Wikipedia"
skos:broader
skos:relatedSynonym
axitinib, N-methyl-2-({3-[(E)-2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl}sulfanyl)benzamide, AG-013736, Inlyta, axitinibum, C22H18N4OS, CNC(=O)c1ccccc1Sc1ccc2c(\\C=C\\c3ccccn3)n[nH]c2c1, InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+, InChIKey=RITAVMQDGBJQJZ-FMIVXFBMSA-N